Phase II study of neoadjuvant irinotecan, capecitabine, oxaliplatin (IXO) followed by chemoradiotherapy (CRT) using concurrent capecitabine for resectable locally advanced rectal cancer

被引：0
|
作者：
Jonker, Derek J. [1 ]
Maroun, Jean Alfred [1 ]
Auer, Rebecca Ann C. [1 ]
Yarom, Nirit [1 ]
Marginean, Celia [1 ]
Shabana, Weal [1 ]
Pantarotto, Jason R. [1 ]
Asmis, Timothy R. [1 ]
Boushey, Robin P. [1 ]
Goodwin, Rachel Anne [1 ]
Kendal, Wayne [1 ]
Tadros, Shaheer [1 ]
Grimard, Laval Jacques [1 ]
Moloo, Husein [1 ]
Friedlich, Martin [1 ]
Bohemier, Caryn [1 ]
Marginean, Horia [1 ]
机构：
[1] Ottawa Hosp Res Inst, Ottawa, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e14571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14571
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II study of neoadjuvant capecitabine, oxaliplatin, and irinotecan (XELOXIRI) in patients with locally advanced rectal cancer
    Matsuda, Chu
    Kudo, Toshihiro
    Morimoto, Yoshihiro
    Kagawa, Yoshinori
    Tei, Mitsuyoshi
    Ide, Yoshihito
    Miyoshi, Norikatsu
    Takahashi, Hidekazu
    Uemura, Mamoru
    Takemasa, Ichiro
    Satoh, Taroh
    Mizushima, Tsunekazu
    Murata, Kohei
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 81 - 90
  • [2] RTOG 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan versus capecitabine and oxaliplatin with concurrent radiation therapy for locally advanced rectal cancer
    Wong, S. J.
    Winter, K.
    Meropol, N. J.
    Anne, R.
    Kachnic, L. A.
    Rashid, A.
    Watson, J. C.
    Mitchell, E. P.
    Pollock, J.
    Lee, R. J.
    Willett, C. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Intensified neoadjuvant chemoradiotherapy (CRT) with capecitabine and irinotecan in patients with locally advanced rectal cancer (LARC): A phase I/II study.
    Klautke, G
    Foitzik, T
    Ludwig, K
    Klar, EJM
    Fietkau, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 292S - 292S
  • [4] A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
    Zhao, Lin
    Bai, Chunmei
    Shao, Yajuan
    Guan, Mei
    Jia, Ning
    Xiao, Yi
    Qiu, Huizhong
    Zhang, Fuquan
    Yang, Ti
    Zhong, Guangxi
    Chen, Shuchang
    [J]. CANCER LETTERS, 2011, 310 (02) : 134 - 139
  • [5] Phase II study of preoperative chemoradiation (CRT) with cetuximab, irinotecan and capecitabine in patients with locally advanced resectable rectal cancer
    Hong, Y. S.
    Kim, D. Y.
    Lee, K. S.
    Lim, S. B.
    Choi, H. S.
    Jeong, S. Y.
    Kim, J. H.
    Im, S. A.
    Kim, T. W.
    Jung, K. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] PHASE II STUDY OF NEOADJUVANT CONCURRENT RADIATION WITH CAPECITABINE/OXALIPLATIN AND CELECOXIB IN UNRESECTABLE LOCALLY ADVANCED RECTAL CANCER
    Cai, G.
    Zhang, Z.
    Zhu, J.
    Gu, W.
    Hu, Y.
    Li, G.
    Cai, S.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 142 - 142
  • [7] RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
    Wong, Stuart J.
    Winter, Kathryn
    Meropol, Neal J.
    Anne, Pramila Rani
    Kachnic, Lisa
    Rashid, Asif
    Watson, James C.
    Mitchell, Edith
    Pollock, Jondavid
    Lee, Robert Jeffrey
    Haddock, Michael
    Erickson, Beth A.
    Willett, Christopher G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1367 - 1375
  • [8] A Phase I Study of Neoadjuvant Capecitabine, Oxaliplatin, and Irinotecan (XELOXIRI) in Patients with Locally Advanced Rectal Cancer
    Kudo, Toshihiro
    Takemasa, Ichiro
    Hata, Tsuyoshi
    Sakai, Daisuke
    Takahashi, Hidekazu
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Satoh, Taroh
    Mizushima, Tsunekazu
    Mori, Masaki
    Doki, Yuichiro
    [J]. ONCOLOGY, 2019, 97 (04) : 211 - 216
  • [9] Phase II Trial of Neoadjuvant Capecitabine (Cp) with Irinotecan (Ir) followed by Capecitabine-based Chemoradiotherapy (CRT) for Patients (pts) with Locally Advanced Rectal Cancer (LARC): A Hoosier Oncology Group Study
    Cardenes, H.
    Sanghani, S.
    Burns, M.
    Robb, B.
    Hinkle, D.
    Johnson, C.
    Yu, M.
    Currie, C.
    Loehrer, P.
    Chiorean, E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S54 - S54
  • [10] Neoadjuvant concurrent chemoradiotherapy with capecitabine and oxaliplatin in patients with locally advanced esophegeal cancer
    Hanan Ahmed Wahba
    Hend Ahmed El-Hadaad
    Ehab Atef Abd-Ellatif
    [J]. Medical Oncology, 2012, 29 : 1693 - 1698
12345